StemCells Therapy

The report “Sequestration: Health Research at the Breaking Point,” released today by Research!America, demonstrates the damaging consequences of potential automatic spending cuts, or sequestration, to the nation’s medical research enterprise and public health, and offers examples on how these cuts would delay scientific discoveries that could lead to new treatments and cures for deadly diseases.Source:http://www.news-medical.net/syndication.axd

Forgive us if we don’t cheer at the prospect of adding 32 million to the total number of Americans who are dozens of pounds too heavy, a count that stood in 2010 at 78 million.Source:http://www.news-medical.net/syndication.axd

Scientists at The Scripps Research Institute have found the first chemical compounds that act to block an enzyme that has been linked to inflammatory conditions such as asthma and arthritis, as well as some inflammation-promoted cancers.Source:http://www.news-medical.net/syndication.axd

The StemCells, Inc., item earlier today incorrectly stated that the disease team applications will come before the board of the California stem cell agency later this month. In fact, they are scheduled to come up at the board meeting in late July. Source:http://californiastemcellreport.blogspot.com/feeds/posts/default?alt=rss

StemCells, Inc., said today it has applied for as much as $40 million in funding from the California stem cell agency for two projects dealing with Alzheimer’s disease and cervical spinal cord injury. The announcement came in a news release dealing with the publicly traded firm’s quarterly earnings. The applications are part of a $240 million [...]

The “stem cell lawyers” item May 9 incorrectly stated that CIRM is expected to have six lawyers on staff in the next fiscal year. The agency expects to have a legal team of six (four lawyers and two assistants).  Source:http://californiastemcellreport.blogspot.com/feeds/posts/default?alt=rss

The California stem cell agency is spending $2.4 million a year on lawyers, a figure that one agency director has described as “awfully bloated.” More than one dollar out of every ten that CIRM spends on its operations goes for legal advice, and the subject came up at a meeting last month of a meeting [...]

The California stem cell agency is in the midst of making significant changes in its lending regulations, but says it is not part of an effort to transfer a $25 million loan to Geron to another company. That does not mean, however, that the agency is not going to transfer the loan at some point. CIRM [...]

A “special advisor” to the $3 billion California stem cell agency has been nominated to the board of directors of Sangamo BioSciences, Inc., a firm that is sharing in a $14.5 million grant from the state research enterprise. She is Saira Ramasastry, managing partner of Life Sciences Advisory, LLC, of Emerald Lake Hills, Ca., and [...]

CARLSBAD, Calif.–(BUSINESS WIRE)– International Stem Cell Corporation (OTCBB: ISCO.OB – News) www.internationalstemcell.com today announced that the Company has developed new technologies to commercialize the use of human parthenogenetic stem cells (hpSC) to treat human diseases.

A new study suggests stem cells may be able to act as a shield to protect the body from the harmful side effects of chemotherapy, the BBC News reported. As chemotherapy drugs attempt to kill cancer drugs, they can also affect the bone marrow and other healthy tissues. In a new study, however, researchers from the Fred Hutchinson Cancer Research Center in Seattle were able to use genetically modified stem cells to protect the bone marrow.

By Daily Mail Reporter PUBLISHED: 16:01 EST, 9 May 2012 | UPDATED: 01:37 EST, 10 May 2012 Stem cells have been transplanted into brain cancer patients for the first time in a bid to protect them against the toxic side effects of chemotherapy. In a study involving three patients, scientists found that two of them survived longer than predicted following the surgery while the other has seen no disease progression after three years of treatment

(CBS News) Patients with brain cancer may face devastating side effects from chemotherapy, but a new study offers a possible solution: stem cells. Yearly dental X-rays raise brain tumor risk, study finds Memorial Hermann hospital in Houston to live tweet brain tumor surgery The stem cells form a shield of sorts against the toxic side effects from chemo, according to the researchers behind the study. It was a small trial that involved only three patients with glioblastoma, the most aggressive and common form of a malignant brain tumor that’s usually fatal.

New research findings show that embryonic stem cells unable to fully compact the DNA inside them cannot complete their primary task: differentiation into specific cell types that give rise to the various types of tissues and structures in the body.

Newswise New research findings show that embryonic stem cells unable to fully compact the DNA inside them cannot complete their primary task: differentiation into specific cell types that give rise to the various types of tissues and structures in the body. Researchers from the Georgia Institute of Technology and Emory University found that chromatin compaction is required for proper embryonic stem cell differentiation to occur. Chromatin, which is composed of histone proteins and DNA, packages DNA into a smaller volume so that it fits inside a cell.

ScienceDaily (May 11, 2012) New research findings show that embryonic stem cells unable to fully compact the DNA inside them cannot complete their primary task: differentiation into specific cell types that give rise to the various types of tissues and structures in the body. Researchers from the Georgia Institute of Technology and Emory University found that chromatin compaction is required for proper embryonic stem cell differentiation to occur. Chromatin, which is composed of histone proteins and DNA, packages DNA into a smaller volume so that it fits inside a cell

ALBANY — Almost halfway through a $600 million state program supporting stem cell research, eight medical schools around New York are reporting progress on projects such as replicating liver cells and eradicating leukemia cells. A new report from Associated Medical Schools of New York updates work at the institutions where hundreds of researchers are starting to unravel causes and potential treatments for conditions ranging from autism to heart disease and cancer. Stem cells are self-renewing and have the ability to develop into other types of cells.

ALBANY — Almost halfway through a $600 million state program supporting stem cell research, eight medical schools around New York are reporting progress on projects such as replicating liver cells and eradicating leukemia cells. A new report from Associated Medical Schools of New York updates work at the institutions where hundreds of researchers are starting to unravel causes and potential treatments for conditions ranging from autism to heart disease. The Empire State Stem Cell Program was intended to fund projects in early stages, including those that initially have been unable to get federal or private funding.

by JEAN ENERSEN / KING 5 Healthlink KING5.com Posted on May 8, 2012 at 6:25 PM Updated today at 6:38 PM Chances are good you’ll lose a tooth or two during your lifetime. Replacement options are limited today, but the future could have you creating teeth from your own cells.

ALBANY, N.Y.